Literature DB >> 2160432

Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus.

A C Wright1, L M Simpson, J D Oliver, J G Morris.   

Abstract

Translucent, avirulent spontaneous phase variants of Vibrio vulnificus MO6-24 reverted back to the original opaque, encapsulated phenotype under both in vivo and in vitro conditions. Two translucent, acapsular mutants, which did not show phase variation, were constructed by using the transposon Tn5 IS50L::phoA (TnphoA). Loss of capsule was accompanied by decreases in virulence, hydrophilicity, and serum resistance. The ability to utilize transferrin-bound iron for growth was lost in only one of the two unencapsulated mutants. Our data emphasize the apparent importance of capsule in the virulence of V. vulnificus and indicate that utilization of transferrin-bound iron is independent of encapsulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160432      PMCID: PMC258721          DOI: 10.1128/iai.58.6.1769-1773.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus.

Authors:  S Yoshida; M Ogawa; Y Mizuguchi
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

2.  Ruthenium red and violet. I. Chemistry, purification, methods of use for electron microscopy and mechanism of action.

Authors:  J H Luft
Journal:  Anat Rec       Date:  1971-11

3.  Vibrio vulnificus (lactose-positive vibrio) and Vibrio parahaemolyticus differ in their susceptibilities to human serum.

Authors:  M M Carruthers; W J Kabat
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

4.  Interaction of Vibrio vulnificus with human polymorphonuclear leukocytes: association of virulence with resistance to phagocytosis.

Authors:  A Kreger; L DeChatelet; P Shirley
Journal:  J Infect Dis       Date:  1981-09       Impact factor: 5.226

5.  Comparison of the abilities of different protein sources of iron to enhance Neisseria meningitidis infection in mice.

Authors:  A B Schryvers; G C Gonzalez
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

6.  Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.

Authors:  M E Klegerman; K M Boyer; C K Papierniak; L Levine; S P Gotoff
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

7.  Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera.

Authors:  A S Kreger; L D Gray; J Testa
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Clinical features and an epidemiological study of Vibrio vulnificus infections.

Authors:  C O Tacket; F Brenner; P A Blake
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226

9.  Spectrum of Vibrio infections in a Gulf Coast community.

Authors:  J R Bonner; A S Coker; C R Berryman; H M Pollock
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

10.  Role of iron in the pathogenesis of Vibrio vulnificus infections.

Authors:  A C Wright; L M Simpson; J D Oliver
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

View more
  103 in total

1.  Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin.

Authors:  J J Fan; C P Shao; Y C Ho; C K Yu; L I Hor
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Relation of capsular polysaccharide production and colonial cell organization to colony morphology in Vibrio parahaemolyticus.

Authors:  J L Enos-Berlage; L L McCarter
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

3.  Differential expression of Vibrio vulnificus capsular polysaccharide.

Authors:  A C Wright; J L Powell; M K Tanner; L A Ensor; A B Karpas; J G Morris; M B Sztein
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Evidence for an intermediate colony morphology of Vibrio vulnificus.

Authors:  Thomas M Rosche; Ben Smith; James D Oliver
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

5.  Genetic distinctions among clinical and environmental strains of Vibrio vulnificus.

Authors:  Maria Chatzidaki-Livanis; Michael A Hubbard; Katrina Gordon; Valerie J Harwood; Anita C Wright
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

6.  Vibrio vulnificus bacteriophage SSP002 as a possible biocontrol agent.

Authors:  Hyun Sung Lee; Slae Choi; Hakdong Shin; Ju-Hoon Lee; Sang Ho Choi
Journal:  Appl Environ Microbiol       Date:  2013-11-08       Impact factor: 4.792

7.  The type IV leader peptidase/N-methyltransferase of Vibrio vulnificus controls factors required for adherence to HEp-2 cells and virulence in iron-overloaded mice.

Authors:  R N Paranjpye; J C Lara; J C Pepe; C M Pepe; M S Strom
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  In vivo resuscitation, and virulence towards mice, of viable but nonculturable cells of Vibrio vulnificus.

Authors:  J D Oliver; R Bockian
Journal:  Appl Environ Microbiol       Date:  1995-07       Impact factor: 4.792

9.  Entry into, and resuscitation from, the viable but nonculturable state by Vibrio vulnificus in an estuarine environment.

Authors:  J D Oliver; F Hite; D McDougald; N L Andon; L M Simpson
Journal:  Appl Environ Microbiol       Date:  1995-07       Impact factor: 4.792

10.  The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice.

Authors:  A C Wright; J G Morris
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.